Wenwen Guo
State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Sciences And Peking Union Medical College
Tianjin, 300020, China
Tianjin, 300020, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
EASIX and sC5b-9 for early identification of adults at high risk of developing TA-TMA after allo-HCT.
Journal: Bone marrow transplantation
Published: April 21, 2026
Evaluation of cyclophosphamide for steroid-refractory hepatic acute graft-vs-host disease after allogeneic hematopoietic stem cell transplantation.
Journal: Frontiers in immunology
Published: August 03, 2025
CBFB::MYH11 MRD after the second chemotherapy cycle: a guide for allogeneic transplantation in favorable-risk AML.
Journal: Bone marrow transplantation
Published: July 20, 2025
Convalescent plasma therapy for COVID-19 prophylaxis in adults early post-hematopoietic stem cell transplantation: one-year outcomes from a randomized controlled trial.
Journal: Frontiers in immunology
Published: May 11, 2025
Divergent prognostic factors in high-risk vs. standard-risk patients aged 50-65 years after allo-HCT for AML/MDS: a single-center retrospective analysis.
Journal: Bone marrow transplantation
Published: March 10, 2025
Impact of pre-transplant body mass index on outcomes in AML patients aged ≥ 50 years after allogeneic hematopoietic cell transplantation.
Journal: Frontiers in immunology
Published: March 03, 2025
Nanocellulose composites with enhanced mechanical and flame-retardant properties based on grafting of inorganic organic/multilayer core-shell matter - MSNs-TMSB/DA/TOCNF.
Journal: Carbohydrate polymers
Published: August 31, 2024
Impact of bone marrow fibrosis on outcomes of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
Journal: Bone marrow transplantation
Published: May 05, 2024
Prophylactic therapy using epigenetic agents for RUNX1::RUNXT1-positive high-risk AML after Allo-HSCT.
Journal: Annals of hematology
Published: March 22, 2024
WT1 gene mutations impact post-transplant relapse in myelodysplastic syndrome with excess blasts 2 patients.
Journal: Annals of hematology
Published: March 21, 2024
Decitabine in combination with idarubicin within a modified busulfan/cyclophosphamide conditioning regimen for patients with advanced myelodysplastic syndrome: A prospective multicenter clinical cohort study.
Journal: Chinese medical journal
Published: October 06, 2023
Last Updated: 09/26/2026